Breaking News
Get 50% Off 0
📌 New AI-picked stocks coming soon. 3 picks from last month are already up +30%...
Get early access
Close

Sernova Corp (PSH0)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.1350 +0.0080    +6.30%
11:35:43 - Delayed Data. Currency in EUR
Type:  Equity
Market:  Germany
ISIN:  CA81752F1062 
S/N:  A411DW
  • Volume: 67,946
  • Bid/Ask: 0.1320 / 0.1350
  • Day's Range: 0.1310 - 0.1380
Sernova 0.1350 +0.0080 +6.30%

Sernova Corp Company Profile

 
Get an in-depth profile of Sernova Corp, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealthcare Equipment & Supplies
SectorHealthcare
Employees

17

Equity Type

ORD

Sernova Biotherapeutics Inc operates as a clinical-stage biotechnology company in Canada. The company develops regenerative medicine therapeutics comprising proprietary Cell Pouch, a bio-hybrid organ system to replicate natural body functions. Its Cell Pouch creates vascularized organs for the longevity and functionality of therapeutic cells and ensures containment for retrievability. The comoany was formerly known as Sernova Corp. and changed its name to Sernova Biotherapeutics Inc in February 2025. Sernova Biotherapeutics Inc is headquartered in London, Canada.

Contact Information

Address 700 Collip Circle Suite 114
London, N6G 4X8
Canada
Phone 519 858 5184
Fax 519 858 5099

Top Executives

Name Age Since Title
Cynthia Pussinen - 2023 CEO & Director
Clive Patience 61 2006 Member of Scientific Advisory Board
Norman C. W. Wong - 2006 Member of Scientific Advisory Board
Steven Paraskevas - 2010 Member of Scientific Advisory Board
Jannette Dufour - 2006 Member of Scientific Advisory Board
Robert A. Gabbay - 2025 Chairman of Clinical Advisory Board
George L. King - - Member of Scientific Advisory Board
Andrew Posselt - 2025 Member of Clinical Advisory Board
David Lillicrap - 2019 Member of Scientific Advisory Board
Stephen Sangha - 2023 Independent Director
Anke M. Schulte - 2020 Member of Global Advisory Board
Sam Wiseman - 2021 Member of Scientific Advisory Board
David Paterson - 2024 Director
Melena Bellin - 2025 Member of Clinical Advisory Board
Bernd Muehlenweg 53 2024 Director
Jonathan M. N. Rigby 57 2024 Interim Chair & CEO
Tanya N. Lewis 54 2025 Director & Observer
Mark A. Atkinson 64 2025 Member of Clinical Advisory Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SVA Comments

Write your thoughts about Sernova Corp
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email